Your request to link to rcsb for NR1/NR2A
- 2A5S: crystal structure of the nr2a ligand binding core in complex with glutamate (10.1038/NATURE04089 )
- 2A5T: crystal structure of the nr1/nr2a ligand-binding cores complex (10.1038/NATURE04089 )
- 3Q41: crystal structure of the glun1 n-terminal domain (ntd) (10.1523/JNEUROSCI.6041-10.2011 )
- 4JWX: glun2a ligand-binding core in complex with propyl-nhp5g (10.1124/MOL.113.085803 )
- 4NF4: crystal structure of glun1/glun2a ligand-binding domain in complex with dcka and glutamate (10.1016/J.NEURON.2013.11.033 )
- 4NF5: crystal structure of glun1/glun2a ligand-binding domain in complex with glycine and d-ap5 (10.1016/J.NEURON.2013.11.033 )
- 4NF6: crystal structure of glun1/glun2a ligand-binding domain in complex with glycine and ppda (10.1016/J.NEURON.2013.11.033 )
- 4NF8: crystal structure of glun1/glun2a ligand-binding domain in complex with glycine and glutamate in peg2000mme (10.1016/J.NEURON.2013.11.033 )
- 4PE5: crystal structure of glun1a/glun2b nmda receptor ion channel (10.1126/SCIENCE.1251915 )
- 4TLL: crystal structure of glun1/glun2b nmda receptor, structure 1 (10.1038/NATURE13548 )
- 4TLM: crystal structure of glun1/glun2b nmda receptor, structure 2 (10.1038/NATURE13548 )
- 5DEX: crystal structure of glun1/glun2a nmda receptor agonist binding domains with glycine and antagonist, phenyl-acepc (10.1073/PNAS.1707752114 )
- 5FXG: glun1b-glun2b nmda receptor in active conformation (10.1038/NATURE17679 )
- 5FXH: glun1b-glun2b nmda receptor in non-active-1 conformation (10.1038/NATURE17679 )
- 5FXI: glun1b-glun2b nmda receptor structure in non-active-2 conformation (10.1038/NATURE17679 )
- 5FXJ: glun1b-glun2b nmda receptor structure-class x (10.1038/NATURE17679 )
- 5FXK: glun1b-glun2b nmda receptor structure-class y (10.1038/NATURE17679 )
- 5H8F: structure of the apo human glun1/glun2a lbd (10.1016/J.NEURON.2016.01.016 )
- 5H8H: structure of the human glun1/glun2a lbd in complex with gne3419 (10.1016/J.NEURON.2016.01.016 )
- 5H8N: structure of the human glun1/glun2a lbd in complex with nam (10.1016/J.NEURON.2016.01.016 )
- 5H8Q: structure of the human glun1/glun2a lbd in complex with gne8324 (10.1016/J.NEURON.2016.01.016 )
- 5I2K: structure of the human glun1/glun2a lbd in complex with 7-{[ethyl(4- fluorophenyl)amino]methyl}-n,2-dimethyl-5-oxo-5h-[1,3]thiazolo[3,2- a]pyrimidine-3-carboxamide (compound 19) (10.1021/ACS.JMEDCHEM.5B02010 )
- 5I2N: structure of the human glun1/glun2a lbd in complex with n-ethyl-7-{[2- fluoro-3-(trifluoromethyl)phenyl]methyl}-2-methyl-5-oxo-5h-[1, 3]thiazolo[3,2-a]pyrimidine-3-carboxamide (compound 29) (10.1021/ACS.JMEDCHEM.5B02010 )
- 5I56: agonist-bound glun1/glun2a agonist binding domains with tcn201 (10.1016/J.NEURON.2016.08.014 )
- 5I57: glutamate- and glycine-bound glun1/glun2a agonist binding domains (10.1016/J.NEURON.2016.08.014 )
- 5I58: glutamate- and glycine-bound glun1/glun2a agonist binding domains with mpx-004 (10.1016/J.NEURON.2016.08.014 )
- 5I59: glutamate- and glycine-bound glun1/glun2a agonist binding domains with mpx 007 (10.1016/J.NEURON.2016.08.014 )
- 5IOU: cryo-em structure of glun1/glun2b nmda receptor in the glutamate/glycine-bound conformation (10.1016/J.CELL.2016.03.028 )
- 5IOV: cryo-em structure of glun1/glun2b nmda receptor in the glutamate/glycine/ro25-6981-bound conformation (10.1016/J.CELL.2016.03.028 )
- 5IPQ: cryo-em structure of glun1/glun2b nmda receptor in the dcka/d-apv- bound conformation, state 2 (10.1016/J.CELL.2016.03.028 )
- 5IPR: cryo-em structure of glun1/glun2b nmda receptor in the dcka/d-apv- bound conformation, state 3 (10.1016/J.CELL.2016.03.028 )
- 5IPS: cryo-em structure of glun1/glun2b nmda receptor in the dcka/d-apv- bound conformation, state 4 (10.1016/J.CELL.2016.03.028 )
- 5IPT: cryo-em structure of glun1/glun2b nmda receptor in the dcka/d-apv- bound conformation, state 5 (10.1016/J.CELL.2016.03.028 )
- 5IPU: cryo-em structure of glun1/glun2b nmda receptor in the dcka/d-apv- bound conformation, state 6 (10.1016/J.CELL.2016.03.028 )
- 5IPV: cryo-em structure of glun1/glun2b nmda receptor in the dcka/d-apv- bound conformation, state 1 (10.1016/J.CELL.2016.03.028 )
- 5JTY: glutamate- and dcka-bound glun1/glun2a agonist binding domains with mpx-007 (10.1016/J.NEURON.2016.08.014 )
- 5KCJ: structure of the human glun1/glun2a lbd in complex with gne6901 (10.1016/J.NEURON.2016.01.016 )
- 5KDT: structure of the human glun1/glun2a lbd in complex with gne0723 (10.1021/ACS.JMEDCHEM.5B02010 )
- 5TP9: structure of the human glun1/glun2a lbd in complex with compound 2 (gne9178) (10.1021/ACSMEDCHEMLETT.6B00388 )
- 5TPA: structure of the human glun1/glun2a lbd in complex with compound 9 (gne3500) (10.1021/ACSMEDCHEMLETT.6B00388 )
- 5TPW: crystal structure of amino terminal domains of the nmda receptor subunit glun1 and glun2a in complex with zinc at the glun2a (10.1016/J.NEURON.2016.11.006 )
- 5TQ0: crystal structure of amino terminal domains of the nmda receptor subunit glun1 and glun2a in the presence of edta (10.1016/J.NEURON.2016.11.006 )
- 5TQ2: crystal structure of amino terminal domains of the nmda receptor subunit glun1 and glun2a in complex with zinc at glun1 and glun2a (10.1016/J.NEURON.2016.11.006 )
- 5U8C: crystal structure of glun1/glun2a ligand-binding domain in complex with glycine and nvp-aam077 (10.1124/MOL.116.107912 )
- 5UN1: crystal structure of glun1/glun2b delta-atd nmda receptor (10.1038/S41586-018-0039-9 )
- 5UOW: triheteromeric nmda receptor glun1/glun2a/glun2b in complex with glycine, glutamate, mk-801 and a glun2b-specific fab, at ph 6.5 (10.1126/SCIENCE.AAL3729 )
- 5UP2: triheteromeric nmda receptor glun1/glun2a/glun2b in complex with glycine, glutamate, ro 25-6981, mk-801 and a glun2b-specific fab, at ph 6.5 (10.1126/SCIENCE.AAL3729 )
- 5VIH: crystal structure of glun1/glun2a nmda receptor agonist binding domains with glycine and antagonist, 4-fluorophenyl-acepc (10.1073/PNAS.1707752114 )
- 5VII: crystal structure of glun1/glun2a nmda receptor agonist binding domains with glycine and antagonist, 4-(3-fluoropropyl)phenyl-acepc (10.1073/PNAS.1707752114 )
- 5VIJ: crystal structure of glun1/glun2a nmda receptor agonist binding domains with glycine and antagonist, 4-bromophenyl-acepc (10.1073/PNAS.1707752114 )
- 6CNA: glun1-glun2b nmda receptors with exon 5 (10.1016/J.NEURON.2018.03.034 )
- 6IRA: structure of the human glun1/glun2a nmda receptor in the glutamate/glycine-bound state at ph 7.8 (10.1016/J.CELREP.2018.11.071 )
- 6IRF: structure of the human glun1/glun2a nmda receptor in the glutamate/glycine-bound state at ph 6.3, class i (10.1016/J.CELREP.2018.11.071 )
- 6IRG: structure of the human glun1/glun2a nmda receptor in the glutamate/glycine-bound state at ph 6.3, class ii (10.1016/J.CELREP.2018.11.071 )
- 6IRH: structure of the human glun1/glun2a nmda receptor in the glutamate/glycine-bound state at ph 6.3, class iii (10.1016/J.CELREP.2018.11.071 )
- 6MM9: diheteromeric nmda receptor glun1/glun2a in the '1-knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 6.1 (10.1016/J.CELL.2018.10.043 )
- 6MMA: diheteromeric nmda receptor glun1/glun2a in the 'extended' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 6.1 (10.1016/J.CELL.2018.10.043 )
- 6MMB: diheteromeric nmda receptor glun1/glun2a in the 'super-splayed' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 6.1 (10.1016/J.CELL.2018.10.043 )
- 6MMG: diheteromeric nmda receptor glun1/glun2a in the '2-knuckle-symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar edta, and at ph 7.4 (10.1016/J.CELL.2018.10.043 )
- 6MMH: diheteromeric nmda receptor glun1/glun2a in the 'extended-2' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at ph 7.4 (10.1016/J.CELL.2018.10.043 )
- 6MMI: diheteromeric nmda receptor glun1/glun2a in the 'splayed-open' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at ph 7.4 (10.1016/J.CELL.2018.10.043 )
- 6MMJ: diheteromeric nmda receptor glun1/glun2a in the 'super-splayed' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at ph 7.4 (10.1016/J.CELL.2018.10.043 )
- 6MMK: diheteromeric nmda receptor glun1/glun2a in the '1-knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 (10.1016/J.CELL.2018.10.043 )
- 6MML: diheteromeric nmda receptor glun1/glun2a in the '2-knuckle-asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 (10.1016/J.CELL.2018.10.043 )
- 6MMM: diheteromeric nmda receptor glun1/glun2a in the 'extended-1' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 (10.1016/J.CELL.2018.10.043 )
- 6MMN: diheteromeric nmda receptor glun1/glun2a in the '2-knuckle-symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 8.0 (10.1016/J.CELL.2018.10.043 )
- 6MMP: diheteromeric nmda receptor glun1/glun2a in the '2-knuckle-symmetric' conformation, in complex with glycine and glutamate, in the presence of 0.1 millimolar edta, and at ph 8.0 (10.1016/J.CELL.2018.10.043 )
- 6MMR: diheteromeric nmda receptor glun1/glun2a in the '2-knuckle-symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, 3 millimolar edta, and at ph 7.4 (10.1016/J.CELL.2018.10.043 )
- 6MMS: triheteromeric nmda receptor glun1/glun2a/glun2a* in the '2-knuckle- symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar edta, and at ph 7.4 (10.1016/J.CELL.2018.10.043 )
- 6MMT: triheteromeric nmda receptor glun1/glun2a/glun2a* in the '1-knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 (10.1016/J.CELL.2018.10.043 )
- 6MMU: triheteromeric nmda receptor glun1/glun2a/glun2a* in the '2-knuckle- asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 (10.1016/J.CELL.2018.10.043 )
- 6MMV: triheteromeric nmda receptor glun1/glun2a/glun2a* extracellular domain in the '2-knuckle-asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 (10.1016/J.CELL.2018.10.043 )
- 6MMW: triheteromeric nmda receptor glun1/glun2a/glun2a* in the '2-knuckle- symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 (10.1016/J.CELL.2018.10.043 )
- 6MMX: triheteromeric nmda receptor glun1/glun2a/glun2a* in the 'extended' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 (10.1016/J.CELL.2018.10.043 )
- 6ODL: crystal structure of glun2a agonist binding domain with 4-butyl-(s)- ccg-iv (10.1016/J.EJMECH.2020.113099 )
- 6OVD: crystal structure of glun1/glun2a nmda receptor agonist binding domains with glycine and antagonist, 3-ethylphenyl-acepc
- 6OVE: crystal structure of glun1/glun2a nmda receptor agonist binding domains with glycine and antagonist, 4-propylphenyl-acepc
- 6USU: crystal structure of glun1/glun2a ligand-binding domain in complex with l689,560 and glutamate (10.1016/J.CELL.2020.05.052 )
- 6USV: crystal structure of glun1/glun2a ligand-binding domain in complex with glycine and sdz 220-040 (10.1016/J.CELL.2020.05.052 )
- 6UZ6: crystal structure of glun1/glun2a-4m mutant ligand-binding domain in complex with glycine and glutamate (10.1038/S41467-020-14321-0 )
- 6UZG: crystal structure of glun1/glun2a-4m mutant ligand-binding domain in complex with glycine and homoquinolinic acid (10.1038/S41467-020-14321-0 )
- 6UZR: crystal structure of glun1/glun2a ligand-binding domain in complex with glycine and homoquinolinic acid (10.1038/S41467-020-14321-0 )
- 6UZW: crystal structure of glun1/glun2a ligand-binding domain in complex with glycine and ubp791 (10.1038/S41467-020-14321-0 )
- 6UZX: crystal structure of glun1/glun2a-4m mutant ligand-binding domain in complex with glycine and ubp791 (10.1038/S41467-020-14321-0 )
- 6WHR: glun1b-glun2b nmda receptor in non-active 2 conformation at 4 angstrom resolution (10.1016/J.CELL.2020.05.052 )
- 6WHS: glun1b-glun2b nmda receptor in non-active 1 conformation at 3.95 angstrom resolution (10.1016/J.CELL.2020.05.052 )
- 6WHT: glun1b-glun2b nmda receptor in active conformation at 4.4 angstrom resolution (10.1016/J.CELL.2020.05.052 )
- 6WHU: glun1b-glun2b nmda receptor in complex with sdz 220-040 and l689,560, class 1 (10.1016/J.CELL.2020.05.052 )
- 6WHV: glun1b-glun2b nmda receptor in complex with sdz 220-040 and l689,560, class 2 (10.1016/J.CELL.2020.05.052 )
- 6WHW: glun1b-glun2b nmda receptor in complex with glun2b antagonist sdz 220- 040, class 1 (10.1016/J.CELL.2020.05.052 )
- 6WHX: glun1b-glun2b nmda receptor in complex with glun2b antagonist sdz 220- 040, class 2 (10.1016/J.CELL.2020.05.052 )
- 6WHY: glun1b-glun2b nmda receptor in complex with glun1 antagonist l689,560, class 1 (10.1016/J.CELL.2020.05.052 )
- 6WI0: glun1b-glun2b nmda receptor in complex with glun1 antagonist l689,560, class 2 (10.1016/J.CELL.2020.05.052 )
- 6WI1: glun1b-glun2b nmda receptor in active conformation stabilized by inter-glun1b-glun2b subunit cross-linking (10.1016/J.CELL.2020.05.052 )